AZIN2 and non-small cell lung carcinoma: In NSCLC, hypoxia significantly upregulated antizyme inhibitor 2 (AZIN2) expression by increasing the binding of HIF-1α and AZIN2 promoters, resulting in decreased E-cadherin expression and increased N-cadherin and vimentin expression, thereby promoting EMT (162).